Ulcerative Colitis Drugs Market Size And Share

  • Report Code : TIPRE00019336
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

궤양성 대장염 치료제 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Ulcerative Colitis Drugs Market Report Ulcerative Colitis Drugs Market Scope and Analysis Ulcerative Colitis Drugs Market Size and Share

Ulcerative Colitis Drugs Market Report Analysis

Ulcerative Colitis Drugs Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Bausch Health Companies Inc. (Salix Pharmaceutical)
  • AbbVie Inc.
  • Johnson and Johnson
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • Merck & Co.
  • Teva Pharmaceuticals Ltd.
  • Takeda Pharmaceuticals
  • Shire

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 약물 유형
  • 생물의약품
  • 코르티코스테로이드
  • 면역조절제 5-아미노살리실산
  • 면역억제제
  • 바이오시밀러
  • 기타
By 투여
  • 경구
  • 주사제
By 적용분야
  • 직장결장염
  • 궤양성직장염
  • 전대장염 좌측대장염
  • 급성중증궤양성대장염
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미